痰热清注射液联合左氧氟沙星治疗肺部恶性肿瘤伴胸腔积液10例
被引量:1
摘要
胸腔积液是肺部恶性肿瘤常见并发症之一。近年来,随着恶性肿瘤发病率的上升,癌性胸腔积液的发病亦显卜升趋势。
出处
《中国中医急症》
2009年第9期1517-1517,共1页
Journal of Emergency in Traditional Chinese Medicine
二级参考文献16
-
1Chronic obstructive pulmonary disease research group of chinese society for respiratory disease. Guideline for diagnosis and management of chronic obstructive pulmonary disease [ J ].Chinese Journal of Tuberculosis and Respiratory Diseases, 2002;25(8) :45
-
2Balbi B, Majori M,Bertacco S, Convertino G, Cuomo A,Donner CF, Pesci A. Inhaled corticosteroids in stable COPD patients:do they have effects on cells and molecular mediators of airway inflammation [ J ] ? Chest, 2000; 117 ( 6 ): 1 633 -1 637
-
3Keatings VM, Collin PD, Scott DM, Barnes PJ. Differences in intefieukin -8 and tumor necrosis factor -alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma[J]. Am J Respir Cdt Care Med,1996; 153:530- 534
-
4De Boer WI, Sont JK, Van Schadewijk A, Stolk J, van Krieken JH, Hiemstra PS. Monocyte chemoattractant protein 1 ,interleukin 8, and chronic airways inflammation in COPD [J ].Journal of Pathol, 2000; 190 ( 5 ) :619 - 626
-
5Riise GC,Ahlstedt S,Larsson S, Enander I, Jones I, Larsson P, Andersson B. Bronchial inflammation in chronic bronchitis assessed by measurement of cell products in bronchial lavage fluid[J]. Thorax, 1995; 50:360 -365
-
6Pesei A, Balbi B,Majori M. Inflammatory cells and mediators in bronchial lavage of patients with chronic obstructive pulmonary disease[J]. Eur Respir J, 1998; 12:380 -386
-
7Tanino M,Betsuyaku T, Takeyabu K, Tanino Y, Yamaguchi E, Miyamoto K, Nishimura M. Increased levels of intefieukin -8 in BAL fluid from smokers susceptible to pulmonary emphysema[J]. Thorax, 2002; 57(5) :405 -411
-
8Mikami M, Llewellyn -Jones CG, Bayley D,Hill SL,Stockley RA. The Chemotacfic Activity of Sputum from Patients with Bronchiectasis [ J ]. Am J Respir Crit Care Med,1998; 157:723 -728
-
9Seggev JS, Thomton WH Jr,Edes TE. Serum leukotriene B4 levels in patient with obstructive pulmonary disease[J]. Chest,1991; 99:289 -291
-
10Beeh KM, Korumann O,Buhl R,Culpitt SV, Giembycz MA, Bame PJ. Neutrophil Chemntachc Activity of Sputum From Patients With COPD: Role of Intedeukin 8 and Leukotriene B4[J]. Chest, 2003; 123(4) :1 240 -1 247
共引文献152
-
1张辉.痰热清注射液治疗儿童急性呼吸道感染的临床观察[J].医学信息,2017,30(7):73-74.
-
2吕秀英,雍雯.痰热清注射液的临床应用[J].医学信息(医学与计算机应用),2014,0(28):177-178. 被引量:2
-
3黄纯美,刘小虹.中医药治疗慢性阻塞性肺疾病作用机制研究进展[J].陕西中医,2008,29(8):1098-1101. 被引量:8
-
4杨红梅,毛兵,钟云青,王蕾,王刚.痰热清注射液治疗慢性阻塞性肺疾病急性加重期随机对照试验的系统评价[J].华西医学,2008,23(6):1244-1249. 被引量:9
-
5李松,华绪柏.痰热清治疗慢性阻塞性肺疾病急性加重期的临床观察[J].中国实用内科杂志,2009,29(S2):71-72. 被引量:6
-
6李廷谦,王刚,王蕾,毛兵.我国中医药临床研究的现状和评价[J].中国循证医学杂志,2005,5(6):431-437. 被引量:36
-
7左秀萍,付桂英,杨郡,陈珊珊.痰热清致心肾功能异常1例[J].中国药业,2005,14(7):73-73. 被引量:20
-
8于伟,苏振静.痰热清注射液治疗下呼吸道感染80例疗效分析[J].职业与健康,2005,21(8):1239-1240. 被引量:3
-
9雷卫平,吴英梅,林翠芬.痰热清注射液的临床应用[J].国际医药卫生导报,2005,11(14):110-113. 被引量:40
-
10沈凌鸿,张红松,乔智灏.无创CPAP通气治疗慢性阻塞性肺疾病急性发作的临床研究[J].广州医药,2005,36(5):18-19.
同被引文献13
-
1曲欢欢,李白雪,燕菲,孙文基.用清除有机自由基DPPH法评价连翘不同部位抗氧化作用[J].中国中医药信息杂志,2008,15(S1):32-34. 被引量:26
-
2苏雪梅,苏青.痰热清注射液治疗老年慢性支气管炎急性发作疗效观察[J].中国中医急症,2005,14(12):1165-1165. 被引量:5
-
3张晓峰.痰热清注射液临床应用概况[J].河南中医,2006,26(4):84-86. 被引量:9
-
4朱其勇.痰热清注射液预防化学性静脉炎的疗效观察[J].现代中西医结合杂志,2006,15(14):1908-1908. 被引量:5
-
5Jenkins P,Welsh A. Computed tomogxaphy appearanceof early radi- ation injury to the lung: correlation with clinical and dosimetric fac- tors[J]. Int J Radiat Oncol Biol Phys,2011,81 (1) :97 - 103.
-
6Takigawa N, Kiura K, Segawa Y, et al. Benefitsand adverse events among elderly patients receiving concurrent chemoradiotherapy for locally advanced nonsmallcell lung cancer: analysis of the Okayama Lung Cancer Study Group trial 0007 [ J ]. J Thorac Oncol,2011,6 (6) :1087 - 1091.
-
7Zhao W,Robbina ME. Inflammation and chronicoxidative stress in radiation-induced late normal tissueinjury:therapeutic complications [J]. Curr Med Chem,2009,16(2):130-143.
-
8黄玲,朱锦锦,邝枣园,李岩,李思宁,伍趣京.黄芩苷对TNF-α诱导血管内皮细胞损伤的影响[J].中药药理与临床,2008,24(2):13-16. 被引量:21
-
9王晓红,李义慧,杨俊泉,胡万宁,张瑞娟,张静.痰热清注射液对血浆内皮素-1的影响及防治放射性肺损伤的疗效观察[J].中国煤炭工业医学杂志,2008,11(12):1823-1825. 被引量:9
-
10李凤玉,刘秀芳,张建宇.放射性肺损伤发生机制的研究进展[J].现代肿瘤医学,2009,17(3):576-578. 被引量:32
二级引证文献8
-
1时美伶,燕晓茹,徐筱青,张培彤.放射性肺炎的中医研究进展[J].吉林中医药,2018,38(12):1476-1479. 被引量:16
-
2段竹云.放射性肺炎66例疗效分析[J].中国现代药物应用,2014,8(15):94-95.
-
3范成普,杜杭根,田勇.痰热清注射液在呼吸系统疾病中的临床应用[J].中国中医急症,2014,23(10):1878-1881. 被引量:13
-
4杨华蕾.肺表面活性物质治疗内源性与外源性新生儿急性肺损伤的临床疗效比较[J].实用心脑肺血管病杂志,2015,23(9):51-53. 被引量:5
-
5李丽,杨静,李颖,姜斌,张丽娜.痰热清、丹参及生脉注射液联合西药治疗放射性肺炎疗效观察[J].现代中西医结合杂志,2016,25(5):507-509. 被引量:12
-
6张海梅,梁华,刘淑娟,贺文茜.痰热清治疗放射性肺炎的临床疗效观察[J].中国基层医药,2016,23(9):1337-1339. 被引量:3
-
7刘鹏,臧建华,唐明,王立忠,邵纬,荆凡静.复方六君子汤治疗急性放射性肺损伤的临床研究[J].世界中医药,2016,11(9):1786-1788. 被引量:8
-
8祝贺,张艳.痰热清对急性放射性肺炎的干预作用及对(白细胞介素)IL-1影响研究[J].大家健康(学术版),2015(14):137-138. 被引量:1
-
1岳顺,潘池,张大红.奈达铂联合氟尿嘧啶持续静滴治疗晚期食管癌临床疗效观察[J].中国肿瘤临床与康复,2008,15(3):229-231. 被引量:2
-
2张云云,胡曙.小剂量三尖杉酯碱静滴治疗原发性肝癌近期疗效观察[J].癌症,1993,12(6):539-540.
-
3王天武,杨正益,何莲.参芪扶正注射液配合化疗治疗恶性肿瘤疗效观察[J].现代中西医结合杂志,2004,13(14):1850-1850. 被引量:1
-
4祁宏伟.复方苦参注射液联合化疗治疗晚期结肠癌临床研究[J].辽宁中医杂志,2016,43(3):547-548. 被引量:10
-
5郭维新,李亮,黎佳全,杨权烈.奈达铂联合大剂量醛氢叶酸、5-氟脲嘧啶持续48小时静滴治疗晚期食管癌初步观察[J].实用医学杂志,2006,22(11):1311-1312. 被引量:2
-
6郭涛,孙顺昌,郭作文,许彬,吕建敏.华蟾素联合化疗治疗恶性肿瘤疗效分析[J].中国肿瘤临床与康复,2005,12(5):450-451. 被引量:2
-
7郭鹏,方圆.左旋门冬酰胺酶致低血糖3例[J].药物不良反应杂志,2004,6(6):412-413. 被引量:3
-
8赵银霞,郑漪.大剂量甲氨喋呤静滴并鞘注预防儿童中枢神经系统白血病的疗效观察[J].宁夏医学院学报,2006,28(1):45-46.
-
9陈慕廉,秦祖尧.中药静滴治疗晚期消化系统肿瘤84例疗效分析[J].实用临床医药杂志,1997,6(6):443-443.
-
10陈贤明.吗啡微量泵静滴治疗骨转移疼痛的临床疗效观察[J].内蒙古中医药,2013,32(7):17-18. 被引量:1